A drug-coated balloon designed for the treatment of femoropopliteal lesions was safe and effective at 2 years in a real-world cohort, according to results presented at the Leipzig Interventional Course.
To assess safety and performance of the DCB (Stellarex, Spectranetics) in the superficial femoral or popliteal arteries, Thomas Zeller, MD, from the department of angiology at the University Heart Center Freiburg-Bad Krozingen in Germany, and colleagues enrolled 371 patients in a prospective, multicenter, single-arm study.
Supported by an independent educational grant from Novartis Pharmaceuticals Corporation.
American Heart Association Scientific Sessions
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.